Author

J. Thomas Janes

Dana-Farber Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andrew A. LaneiD· 1 shared Catherine J. WuiD· 1 shared Corey S. CutleriD· 1 shared Gabriel Kenneth GriffiniD· 1 shared Haynes HeatoniD· 1 shared Jacqueline Suen GarciaiD· 1 shared Jerome RitziD· 1 shared John KorethiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew A. LaneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS

Nurefsan E. Sariipek, Ksenia R. Safina, Wesley S. Lu, Shuqiang Li, J. Thomas Janes, McKayla Van Orden, Kenneth J. Livak, Haynes Heaton, Vincent T. Ho, John Koreth, Marlise Rachael Luskin, Gabriel Kenneth Griffin, Jacqueline Suen Garcia, Robert Coleman Lindsley, Corey S. Cutler, , Peter van Galen

The paper identifies recipient stem-cell persistence and T-cell dysregulation as predictors of relapse after HSCT in AML/MDS by analyzing single-cell RNA and TCR sequencing data.

bioRxiv · Nov 13, 2025 · PreprintCancer Biology